litlas
Log inCreate account

Xiaping He

Active 1999–2024

43
Papers
18,028
Citations
33
h-index
42
i10-index

Citations

Citations per year for Xiaping He1990: 1 citations1994: 1 citations1998: 1 citations2000: 3 citations2001: 5 citations2002: 4 citations2003: 4 citations2004: 13 citations2005: 10 citations2006: 32 citations2007: 81 citations2008: 126 citations2009: 148 citations2010: 259 citations2011: 299 citations2012: 311 citations2013: 332 citations2014: 294 citations2015: 329 citations2016: 313 citations2017: 291 citations2018: 286 citations2019: 684 citations2020: 615 citations2021: 688 citations2022: 442 citations2023: 361 citations2024: 459 citations2025: 202 citations2026: 14 citations1991–1993: no citations, so these years are not shown1995–1997: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,800 citing papers, 31.6% of this breakdownChina: 945 citing papers, 10.7% of this breakdownUnited Kingdom: 578 citing papers, 6.5% of this breakdownItaly: 363 citing papers, 4.1% of this breakdownCanada: 352 citing papers, 4% of this breakdownGermany: 320 citing papers, 3.6% of this breakdownAustralia: 288 citing papers, 3.3% of this breakdownFrance: 288 citing papers, 3.2% of this breakdownSpain: 274 citing papers, 3.1% of this breakdownNetherlands: 198 citing papers, 2.2% of this breakdownSweden: 188 citing papers, 2.1% of this breakdownSouth Korea: 177 citing papers, 2% of this breakdown
0%31.6%Other 23.6%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology58.7%
  • Medicine32.9%
  • Immunology and Microbiology2.4%
  • Computer Science2.1%
  • Neuroscience1.1%
  • Chemistry0.8%
  • Other2%

Topics

  • Breast Cancer Treatment Studies6.2%
  • Cancer Cells and Metastasis5.1%
  • Cancer Genomics and Diagnostics4.9%
  • Gene expression and cancer classification3.7%
  • HER2/EGFR in Cancer Research3.5%
  • Bioinformatics and Genomic Networks3%
  • Other73.6%

Coauthors

All papers

Open in search
  1. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    Authors: Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang, Samuel Leung, David Voduc, Tammi L. Vickery, Sherri R. Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine R. Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard - Journal of Clinical Oncology 2009 cited by 4,887

  2. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

    Authors: Aleix Prat, Joel S. Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I. Herschkowitz, Xiaping He, Charles M. Perou - Breast Cancer Research 2010 cited by 2,135

  3. B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

    Authors: Daniel P. Hollern, Nuo Xu, Aatish Thennavan, Cherise Ryan Glodowski, Susana García‐Recio, Kevin R. Mott, Xiaping He, Joseph P. Garay, Kelly Carey-Ewend, David Marron, John Ford, Siyao Liu, Sarah C. Vick, Miguel Martín, Joel S. Parker, Benjamin G. Vincent, Jonathan S. Serody, Charles M. Perou - Cell 2019 cited by 490

  4. MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery

    Authors: Derek Y. Chiang, Zheng Zeng, Piotr A. Mieczkowski, Darshan Singh, Jinze Liu, Jan F. Prins, James N. MacLeod, Yan Huang, Kai Wang, S. J. Coleman, Xiaping He, Gleb L. Savich, Sara A. Grimm, Charles A. Perou - Nucleic Acids Research 2010 cited by 1,245

  5. Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

    Authors: James S. Duncan, Martin C. Whittle, Kazuhiro Nakamura, Amy N. Abell, Alicia A. Midland, Jon S. Zawistowski, Nancy L. Johnson, Deborah A. Granger, Nicole Vincent Jordan, David B. Darr, Jerry Usary, Pei Fen Kuan, David M. Smalley, Ben Major, Xiaping He, Katherine A. Hoadley, Bing Zhou, Norman E. Sharpless, Charles M. Perou, William Y. Kim, Shawn M. Gomez, Xin Chen, Jian Jin, Stephen V. Frye, H. Shelton Earp, Lee M. Graves, Gary L. Johnson - Cell 2012 cited by 750

  6. Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

    Authors: Shunqiang Li, Dong Shen, Jieya Shao, Robert J. Crowder, Wenbin Liu, Aleix Prat, Xiaping He, Shuying Liu, Jeremy Hoog, Charles Lu, Li Ding, Obi L. Griffith, Christopher A. Miller, Dave Larson, Robert S. Fulton, Michelle Harrison, Tom Mooney, Joshua F. McMichael, Jingqin Luo, Tao Yu, Rodrigo Gonçalves, Christopher Schlosberg, Jeffrey Hiken, Laila Saied, César Sánchez, Therese Giuntoli, Caroline Bumb, Crystal Cooper, Robert T. Kitchens, Austin Lin, Chanpheng Phommaly, Sherri R. Davies, Jin Zhang, Megha Shyam Kavuri, Donna McEachern, Yi Dong, X. Cynthia, Timothy Pluard, Michael Naughton, Ron Bose, Rama Suresh, R. McDowell, Loren Michel, Rebecca Aft, William E. Gillanders, Katherine DeSchryver, Richard K. Wilson, Shaomeng Wang, Gordon B. Mills, Ana M. González-Angulo, John R. Edwards, Christopher A. Maher, Charles M. Perou, Elaine R. Mardis, Matthew J. Ellis - Cell Reports 2013 cited by 625

  7. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer

    Authors: Marni B. Siegel, Xiaping He, Katherine A. Hoadley, Alan P. Hoyle, Julia B. Pearce, Amy Garrett, Sunil Kumar, Vincent Moylan, Claudia Brady, Amanda E.D. Van Swearingen, David Marron, Gaorav P. Gupta, Leigh B. Thorne, Niamh E. Kieran, Chad Livasy, Elaine R. Mardis, Joel S. Parker, Mengjie Chen, Carey K. Anders, Lisa A. Carey, Charles M. Perou - Journal of Clinical Investigation 2018 cited by 195

  8. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

    Authors: Susana García‐Recio, Aatish Thennavan, Michael P. East, Joel S. Parker, Juan Miguel Cejalvo, Joseph P. Garay, Daniel P. Hollern, Xiaping He, Kevin R. Mott, Patricia Galván, Cheng Fan, Sara R. Selitsky, Alisha R. Coffey, David Marron, Fara Brasó‐Maristany, Octavio Burgués, Joan Albanell, Federico Rojo, Aňa Lluch, Eduardo Martínez de Dueñas, Jeffery M. Rosen, Gary L. Johnson, Lisa A. Carey, Aleix Prat, Charles M. Perou - Journal of Clinical Investigation 2020 cited by 110

  9. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

    Authors: Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee, Jane Fridlyand, Ayşegül A. Şahin, Roshan Agarwal, Corwin Joy, Wenbin Liu, David Stivers, Keith Baggerly, Mark Carey, Aňa Lluch, Carlos Monteagudo, Xiaping He, Victor Weigman, Cheng Fan, Juan Palazzo, Gabriel N. Hortobágyi, Laura K. Nolden, Nicholas J. Wang, Vicente Valero, Joe W. Gray, Charles M. Perou, Gordon B. Mills - Cancer Research 2009 cited by 857

  10. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer

    Authors: Jonathan T. Lei, Jieya Shao, Jin Zhang, Michael D. Iglesia, Doug W. Chan, Jin Cao, Meenakshi Anurag, Purba Singh, Xiaping He, Yoshimasa Kosaka, Ryoichi Matsunuma, Robert J. Crowder, Jeremy Hoog, Chanpheng Phommaly, Rodrigo Gonçalves, Susana Ramalho, Raquel Mary Rodrigues Peres, Nindo Punturi, Cheryl Schmidt, Alex Bartram, Eric Jou, Vaishnavi Devarakonda, Kimberly R. Holloway, Weiyi Lai, Oliver Hampton, Anna Rogers, Ethan Tobias, Poojan A. Parikh, Sherri R. Davies, Shunqiang Li, X. Cynthia, Vera J. Suman, Kelly K. Hunt, Mark A. Watson, Katherine A. Hoadley, E. Aubrey Thompson, Xi Chen, Shyam M. Kavuri, Chad J. Creighton, Christopher A. Maher, Charles M. Perou, Svasti Haricharan, Matthew J. Ellis - Cell Reports 2018 cited by 110

  11. Entinostat induces antitumor immune responses through immune editing of tumor neoantigens

    Authors: Andrew Truong, Mi Zhou, Bhavani Krishnan, Takanobu Utsumi, Ujjawal Manocha, Kyle G. Stewart, Wolfgang Beck, Tracy L. Rose, Matthew I. Milowsky, Xiaping He, Christof C. Smith, Lisa M. Bixby, Charles M. Perou, Sara E. Wobker, Sean T. Bailey, Benjamin G. Vincent, William Y. Kim - Journal of Clinical Investigation 2021 cited by 82

  12. Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

    Authors: Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet, Timothy J. Stuhlmiller, Adriana S. Beltrán, José F. Olivares-Quintero, Darshan Singh, Noah Sciaky, Joel S. Parker, Naim U. Rashid, Xin Chen, James S. Duncan, Martin C. Whittle, Steven P. Angus, Sara H. Velarde, Brian T. Golitz, Xiaping He, Charlene Santos, David B. Darr, Kristalyn K. Gallagher, Lee M. Graves, Charles M. Perou, Lisa A. Carey, H. Shelton Earp, Gary L. Johnson - Cancer Discovery 2017 cited by 185

  13. Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells

    Authors: Xiaping He, Zhenhui Li, Joshua D. Rizak, Shihao Wu, Zhengbo Wang, Rongqiao He, Min Su, Dongdong Qin, Jingkun Wang, Xintian Hu - Frontiers in Neuroscience 2017 cited by 95

  14. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling

    Authors: Wei Zhao, Xiaping He, Katherine A. Hoadley, Joel S. Parker, D. Neil Hayes, Charles M. Perou - BMC Genomics 2014 cited by 338

  15. The molecular portraits of breast tumors are conserved across microarray platforms

    Authors: Maria Tretiakova, Matthew G. Ewend, Michael Mullins, Chad Livasy, Heidi J. Hansen, Mary C. Mone, Rita Nanda, Joel S. Parker, Edward Nelson, Lynn G. Dressler, J. S. Marron, Evangeline Reynolds, Cheng Fan, Charles M. Perou, Alejandra Ruiz Orrico, Laurent Perreard, Junyuan Wu, Philip S. Bernard, John F. Quackenbush, Yudong Liu, Zhiyuan Hu, Lynda Sawyer, Andrew B. Nobel, Daniel Oh, Juan Palazzo, Matthew J. Ellis, Xiaping He, Lisa A. Carey, Bahjat F. Qaqish, Olufunmilayo I. Olopade, Donna Dreher - BMC Genomics 2006 cited by 1,470

  16. Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases

    Authors: Katherine A. Hoadley, Marni B. Siegel, Krishna Kanchi, Christopher A. Miller, Li Ding, Zhao Wei, Xiaping He, Joel S. Parker, Michael C. Wendl, Robert S. Fulton, Ryan Demeter, Richard K. Wilson, Lisa A. Carey, Charles M. Perou, Elaine R. Mardis - PLoS Medicine 2016 cited by 108

  17. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer

    Authors: Erika J. Crosby, Chaitanya R. Acharya, Anthony-Fayez Haddad, Christopher A. Rabiola, Gangjun Lei, Jun-Ping Wei, Xiaoyi Yang, Tao Wang, Cong-Xiao Liu, Kay‐Uwe Wagner, William J. Muller, Lewis A. Chodosh, Gloria Broadwater, Terry Hyslop, Jonathan H. Shepherd, Daniel P. Hollern, Xiaping He, Charles M. Perou, Shengjie Chai, Benjamin K. Ashby, Benjamin G. Vincent, Joshua C. Snyder, Jeremy Force, Michael A. Morse, H. Kim Lyerly, Zachary C. Hartman - Clinical Cancer Research 2020 cited by 52

  18. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

    Authors: Jason I. Herschkowitz, Xiaping He, Cheng Fan, Charles M. Perou - Breast Cancer Research 2008 cited by 261

  19. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes

    Authors: Aleix Prat, Olga Karginova, Joel S. Parker, Cheng Fan, Xiaping He, Lisa M. Bixby, J. Chuck Harrell, Erick Roman, Bárbara Adamo, Melissa A. Troester, Charles M. Perou - Breast Cancer Research and Treatment 2013 cited by 203

  20. A compact VEGF signature associated with distant metastases and poor outcomes

    Authors: Zhiyuan Hu, Cheng Fan, Chad Livasy, Xiaping He, Daniel Oh, Matthew G. Ewend, Lisa A. Carey, Subbaya Subramanian, Robert B. West, Francis Ikpatt, Olufunmilayo I. Olopade, Matt van de Rijn, Charles M. Perou - BMC Medicine 2009 cited by 188

  21. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival

    Authors: Victor Weigman, Hann‐Hsiang Chao, Andrey A. Shabalin, Xiaping He, Joel S. Parker, Silje Nord, Tatyana A. Grushko, Dezheng Huo, Chika Nwachukwu, Andrew B. Nobel, Vessela N. Kristensen, Anne‐Lise Børresen‐Dale, Olufunmilayo I. Olopade, Charles M. Perou - Breast Cancer Research and Treatment 2011 cited by 905

  22. Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches

    Authors: Arran K. Turnbull, Cigdem Selli, Carlos Martinez-Perez, Anu Fernando, Lorna Renshaw, Jane Keys, Jonine Figueroa, Xiaping He, Maki Tanioka, Alison F. Munro, Lee Murphy, Angie Fawkes, Richard Clark, Audrey Coutts, Charles M. Perou, Lisa A. Carey, Michael J. Dixon, Andrew H. Sims - BMC Bioinformatics, BMC Bioinform. 2007 cited by 54

  23. The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment

    Authors: Fan Chen, Na Wang, Xinyan Tian, Juan Su, Qin Yan, Rongqiao He, Xiaping He - Pharmaceutics 2023 cited by 22

  24. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse

    Authors: J. Chuck Harrell, Aleix Prat, Joel S. Parker, Cheng Fan, Xiaping He, Lisa A. Carey, Carey K. Anders, Matthew G. Ewend, Charles M. Perou - Breast Cancer Research and Treatment 2011 cited by 229